Detalles de la búsqueda
1.
Importance and Potential of European Cross-Border Deceased Donor Organ Allocation Through FOEDUS-EOEO Platform.
Transpl Int
; 36: 11327, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38020752
2.
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
Int J Mol Sci
; 24(2)2023 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36674615
3.
Cytoreductive surgery followed by chemotherapy and olaparib maintenance in BRCA 1/2 mutated recurrent ovarian cancer: a retrospective MITO group study.
Int J Gynecol Cancer
; 31(7): 1031-1036, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33990353
4.
Olaparib as maintenance therapy in patients with BRCA 1-2 mutated recurrent platinum sensitive ovarian cancer: Real world data and post progression outcome.
Gynecol Oncol
; 156(1): 38-44, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31699415
5.
Standardization of CTC AR-V7 PCR assay and evaluation of its role in castration resistant prostate cancer progression.
Prostate
; 79(1): 54-61, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30141201
6.
Ki67 as a Predictor of Response to PARP Inhibitors in Platinum Sensitive BRCA Wild Type Ovarian Cancer: The MITO 37 Retrospective Study.
Cancers (Basel)
; 15(4)2023 Feb 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36831376
7.
Addition of Niraparib to Best Supportive Care as Maintenance Treatment in Patients with Advanced Urothelial Carcinoma Whose Disease Did Not Progress After First-line Platinum-based Chemotherapy: The Meet-URO12 Randomized Phase 2 Trial.
Eur Urol
; 83(1): 82-89, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36216658
8.
Compassionate Use Program of Ipilimumab and Nivolumab in Intermediate or Poor Risk Metastatic Renal Cell Carcinoma: A Large Multicenter Italian Study.
Cancers (Basel)
; 14(9)2022 05 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35565422
9.
Effect of systemic therapies or best supportive care after disease progression to both nivolumab and cabozantinib in metastatic renal cell carcinoma: The Meet-Uro 19BEYOND study.
Cancer Med
; 11(16): 3084-3092, 2022 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35312175
10.
The prognostic value of baseline and early variations of peripheral blood inflammatory ratios and their cellular components in patients with metastatic renal cell carcinoma treated with nivolumab: The Δ-Meet-URO analysis.
Front Oncol
; 12: 955501, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36212433
11.
Vigilance for Medical Products of Human Origin-Progress on the Notify Library's Global Effort to Share Information and Learning.
Transplantation
; 105(9): 1921-1929, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33449611
12.
Heterogeneous response to target therapy in metastatic papillary renal cell carcinoma evaluated by morphologic and metabolic multimodality imaging: A case report.
Medicine (Baltimore)
; 98(50): e18093, 2019 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-31852068
13.
SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand.
Oncotarget
; 9(38): 25355-25382, 2018 May 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-29861877
14.
Characterization of a rare nonpathogenic sequence variant (c.1905C>T) of the dihydropyrimidine dehydrogenase gene (DPYD).
Int J Biol Markers
; 32(3): e357-e360, 2017 Jul 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-28430339
15.
[Genomics of lung adenocarcinoma: pathogenetic significance and clinical applications.] / Genomica dell'adenocarcinoma polmonare: significato patogenetico e applicazioni cliniche.
Recenti Prog Med
; 107(12): 652-672, 2016 Dec.
Artículo
en Italiano
| MEDLINE | ID: mdl-27997009
Resultados
1 -
15
de 15
1
Próxima >
>>